Status:
COMPLETED
Perennial Allergic Rhinitis Study In Pediatric Subjects
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rhinitis, Allergic, Perennial
Eligibility:
All Genders
2-12 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine if the investigational drug is effective and safe in children with perennial allergic rhinitis.
Detailed Description
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 50mcg an...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Diagnosis of perennial allergic rhinitis.
- Exclusion criteria:
- Have significant concomitant medical conditions.
- Use of corticosteroids or other allergy medications during the study.
- Have abnormal ECG.
- Have laboratory abnormality.
- Have abnormal eye exam.
Exclusion
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2005
Estimated Enrollment :
558 Patients enrolled
Trial Details
Trial ID
NCT00108914
Start Date
February 1 2005
End Date
November 1 2005
Last Update
January 19 2017
Active Locations (66)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Costa Mesa, California, United States, 92626
2
GSK Investigational Site
Cudahy, California, United States, 90201
3
GSK Investigational Site
Long Beach, California, United States, 90806
4
GSK Investigational Site
Long Beach, California, United States, 90808